Form 4: Accendra Health COO Sells Shares for Tax Obligations

Accendra Health's EVP and COO, Perry A. Bernocchi, disposed of 20,841 common shares to cover tax withholding obligations related to restricted stock vesting.

Summary

• Perry A. Bernocchi, Executive Vice President and Chief Operating Officer of Accendra Health Inc., reported a transaction involving the company's common stock.
• On March 20, 2026, Bernocchi disposed of 20,841 shares of common stock.
• The shares were surrendered to the Issuer (Accendra Health Inc.) to satisfy tax withholding obligations in connection with the vesting of restricted stock.
• The price per share for this transaction was $2.03.
• Following this reported transaction, Bernocchi beneficially owns 321,821 shares of Accendra Health Inc. common stock directly.
• The transaction was made pursuant to a contract, instruction, or written plan for the purchase or sale of equity securities intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event. It is a standard, non-discretionary transaction related to executive compensation and tax obligations, not a discretionary sale indicating a change in management's confidence.

Future Outlook

The filing does not contain any forward-looking statements or guidance regarding the company's future performance or outlook.

Industry Context

StockSavvy.ai notes that transactions involving the surrender of shares to cover tax withholding obligations upon the vesting of restricted stock are a common and routine occurrence for executives receiving equity compensation. This type of transaction is generally not indicative of an executive's sentiment regarding the company's future prospects.

Stakeholder Impact

• Minimal impact on shareholders as this is a routine, non-discretionary transaction by an executive to cover tax obligations, rather than a discretionary sale.

Key Dates

Recommendation

This Form 4 filing details a routine, non-discretionary transaction by an executive to cover tax obligations related to restricted stock vesting. It does not provide new information regarding the company's operational performance, financial health, or strategic direction that would warrant a change in investment recommendation. Therefore, a 'hold' recommendation is appropriate as there is no new fundamental data to alter an existing investment thesis.

Keywords

Accendra Health, ACH, Form 4, Insider Transaction, Stock Sale, Tax Withholding, Restricted Stock, Perry A. Bernocchi, Corporate Officer